title: Cervical cancer control in India: taking evidence to action.
abstract: The most prevalent types of human papillomavirus in cervical cancer in India are HPV 16 and HPV 18, found in 60.7 per cent and 16 per cent of cases respectively. A comprehensive strategy with a judicious mix of interventions on health promotion, specific protection (vaccination), early diagnosis (screening), and treatment should be instituted to prevent and control cervical cancer in India. Proponents of vaccination and screening argue for enhanced investments on these interventions based on their relative cost-effectiveness. For policymakers, the major concerns about these interventions remain affordability and cost to government. Herein we try to review comprehensively the evidence on prevention and control interventions and to recommend appropriate policies to guide public health decision-making.
authors.affiliation: Public Health Foundation of India, Indian Institute of Public Health-Delhi, India.
authors.forename: Habib Hasan
authors.initials: HH
authors.lastname: Farooqui
authors.forename: Sanjay
authors.initials: S
authors.lastname: Zodpey
mesh_terms: D003362:Cost-Benefit Analysis; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D007194:India; D030361:Papillomavirus Infections / Q000191:economics / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D011315:Preventive Medicine; D011640:Public Policy; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears / Q000191:economics
chemical_list: D053918:Papillomavirus Vaccines